Overview
- 185 inspections across 138 sites are on record.
- 177 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2015-11-20.
At a glance
Inspections
185
Sites
138
Observations
177
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Eurofins Spinnovation Analytical BV | 20 Nov 2015 | Human Drugs | |
| Eurofins PHAST Development GmbH & Co. KG | 17 Nov 2015 | Human Drugs | |
| Bayer AG | 12 Nov 2015 | Human Drugs | |
| Bayer Weimar GmbH und Co. KG | 5 Nov 2015 | Human Drugs | |
| ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. (No. 36 Kangyang Avenue) | 24 Sep 2015 | Human Drugs |
Sites inspected
Eurofins Spinnovation Analytical BVOss, Netherlands1 insp.
Eurofins PHAST Development GmbH & Co. KGKonstanz, Germany1 insp.
Bayer AGBergkamen, Germany1 insp.
Bayer Weimar GmbH und Co. KGWeimar, Germany1 insp.
ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. (No. 36 Kangyang Avenue)Shaoxing, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Lucas B Leake12 shared
Kenneth Boehnen8 shared
Diana L Ayala5 shared
Cheryl D Mccall4 shared
Linda Thai2 shared
Marcus F Yambot1 shared
Joey V Quitania1 shared
Lisa M Schultz1 shared
John A Daubenspeck1 shared
Allen F Hall1 shared
Full investigator report
Get the verbatim findings behind Timothy T Kapsala's 177 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site